Navigation Links
Precision Therapeutics President and CEO Sean McDonald Named Ernst & Young Entrepreneur of the Year(R) 2008 Regional Award Winner
Date:7/2/2008

PITTSBURGH, July 2 /PRNewswire/ -- Precision Therapeutics today announced that its President and Chief Executive Officer Sean McDonald received the Ernst & Young Entrepreneur of the Year(R) 2008 Award in the Applied Science category in the Upstate New York, Western Pennsylvania and West Virginia region. This award recognizes outstanding entrepreneurs who are building and leading dynamic growth businesses. McDonald was selected by an independent panel of judges and the award was presented at an Ernst & Young Entrepreneur of the Year gala event at the Carnegie Music Hall in Pittsburgh on Friday, June 27, 2008.

"Being named an Ernst & Young Entrepreneur of the Year is a great honor for me and my team as we work towards our goal of improving the lives of people living with cancer," said McDonald. "This is not only a win for Precision; it is also a win for the growing life science industry in the Pittsburgh region."

Sean joined Precision Therapeutics in 2001 and serves as President and CEO. Prior to joining Precision, Sean founded Automated Healthcare in 1992, developing the first robotics-based solution to hospital pharmacy management. Automated Healthcare was successfully acquired by McKesson Corporation in 1996. In addition to his current award, Sean has been recognized with a 1999 Ernst & Young Entrepreneur of the Year Award, a 1999 Carnegie Award for Excellence in Science and Technology, the Smithsonian Institution Award for heroic achievement in information technology, and the Pittsburgh Life Sciences Greenhouse 2004 PIONEER award. Sean received a BS in Engineering from the University of Pennsylvania and an MS in Electrical Engineering and Computer Science from the University of Florida.

About Precision Therapeutics

Precision Therapeutics is a diagnostics services company dedicated to providing physicians and patients with actionable clinical information to personalize cancer treatments. Precision's ChemoFx(R) test measures an individual patient's tumor response to a range of therapeutic alternatives under consideration by a physician.

For more information, please visit http://www.precisiontherapeutics.com.

About Ernst & Young's Entrepreneur Of The Year

Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Ernst & Young's Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs. The award makes a difference through the unique way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Ernst & Young Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.

For more information, please visit http://www.ey.com.


'/>"/>
SOURCE Precision Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Applied Precision Announces Sale of Life Sciences Business Unit to Senior Management and Telegraph Hill Partners
2. Precision Therapeutics Adds 8 Million Covered Lives Under Contract
3. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
4. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%
5. Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order
6. New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput
7. Varian Medical Systems to Unveil RapidArc(TM) Volumetric Arc Therapy and Other Products Designed to Speed Delivery of Precision Radiotherapy and Brachytherapy
8. Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years
9. 2008 International Federation of Adipose Therapeutics and Science (IFATS) Conference Date Set
10. Jerry Steffl Joins Prime Therapeutics as Vice President, Government Affairs
11. Fischman receives Pharmacology/Therapeutics/Toxicology Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... ... FileHold's document management software has been implemented by DocuSyst ... for FileHold software that is pay per user subscription-based and also does on-premise ... web services API. DocuSyst also advises clients on fully functioning back up technologies ...
(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... ... showing greater than 50% lower incidence rate of type 2 diabetes in the ... averages. ”It is time to make a change in public health,” states Carole ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com recently ... in Mole removal products. , Moles are derived from a cluster of melanin when ... all the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
(Date:2/8/2016)... NV (PRWEB) , ... February 08, 2016 , ... Guruji ... February 9th, 10th and 11th, 2016 in honor of his birthday on February 10th. ... true happiness. Mahendra Trivedi is known by over 250,000 people from over 40 ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research by the ... dental technicians to be certified or obtain continuing education. To increase patient awareness ... In Your Mouth?” campaign to inform dentists and patients about the possible lack ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
(Date:2/8/2016)... February 8, 2016 ... published by Allied Market Research titled, "World ... Forecasts, 2014-2020", estimates the world synthetic biology market ... and sequencing technology segment would continue to lead ... tools segment, collectively, held around half of the ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, ... heute eine Infografik mit dem Titel „Epilepsy ... Welt), mit der der Krankheit gegenüber ein ... dazu ermutigen soll, Medikamentenresistenz bei Epilepsie auf ... allgemeinen Diskussion zu machen. Mithilfe der neuen ...
Breaking Medicine Technology: